nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—SIGMAR1—amyotrophic lateral sclerosis	0.546	1	CbGaD
Amiodarone—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.208	0.691	CbGbCtD
Amiodarone—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0927	0.309	CbGbCtD
Amiodarone—Thyroid neoplasm—Riluzole—amyotrophic lateral sclerosis	0.011	0.114	CcSEcCtD
Amiodarone—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0353	CcSEcCtD
Amiodarone—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0195	CcSEcCtD
Amiodarone—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0189	CcSEcCtD
Amiodarone—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0186	CcSEcCtD
Amiodarone—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0186	CcSEcCtD
Amiodarone—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0178	CcSEcCtD
Amiodarone—THRA—hindbrain—amyotrophic lateral sclerosis	0.00168	0.0893	CbGeAlD
Amiodarone—THRB—hindbrain—amyotrophic lateral sclerosis	0.00168	0.0893	CbGeAlD
Amiodarone—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0175	CcSEcCtD
Amiodarone—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0172	CcSEcCtD
Amiodarone—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0172	CcSEcCtD
Amiodarone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0164	CcSEcCtD
Amiodarone—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0156	CcSEcCtD
Amiodarone—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0155	CcSEcCtD
Amiodarone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0153	CcSEcCtD
Amiodarone—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0145	CcSEcCtD
Amiodarone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0135	CcSEcCtD
Amiodarone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0134	CcSEcCtD
Amiodarone—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0131	CcSEcCtD
Amiodarone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0131	CcSEcCtD
Amiodarone—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0131	CcSEcCtD
Amiodarone—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00125	0.013	CcSEcCtD
Amiodarone—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0123	CcSEcCtD
Amiodarone—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0123	CcSEcCtD
Amiodarone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0119	CcSEcCtD
Amiodarone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0117	CcSEcCtD
Amiodarone—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0111	CcSEcCtD
Amiodarone—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0109	CcSEcCtD
Amiodarone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0109	CcSEcCtD
Amiodarone—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0106	CcSEcCtD
Amiodarone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0105	CcSEcCtD
Amiodarone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00099	0.0103	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0101	CcSEcCtD
Amiodarone—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000969	0.0101	CcSEcCtD
Amiodarone—THRA—brainstem—amyotrophic lateral sclerosis	0.000965	0.0512	CbGeAlD
Amiodarone—THRB—brainstem—amyotrophic lateral sclerosis	0.000965	0.0512	CbGeAlD
Amiodarone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000949	0.00986	CcSEcCtD
Amiodarone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000941	0.00978	CcSEcCtD
Amiodarone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000911	0.00947	CcSEcCtD
Amiodarone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000873	0.00907	CcSEcCtD
Amiodarone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00897	CcSEcCtD
Amiodarone—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00881	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000827	0.00859	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00081	0.00842	CcSEcCtD
Amiodarone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00081	0.00842	CcSEcCtD
Amiodarone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000778	0.00809	CcSEcCtD
Amiodarone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00803	CcSEcCtD
Amiodarone—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00783	CcSEcCtD
Amiodarone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00771	CcSEcCtD
Amiodarone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000731	0.0076	CcSEcCtD
Amiodarone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00753	CcSEcCtD
Amiodarone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00751	CcSEcCtD
Amiodarone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000718	0.00746	CcSEcCtD
Amiodarone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000712	0.0074	CcSEcCtD
Amiodarone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00721	CcSEcCtD
Amiodarone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00717	CcSEcCtD
Amiodarone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00705	CcSEcCtD
Amiodarone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00686	CcSEcCtD
Amiodarone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00672	CcSEcCtD
Amiodarone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000635	0.0066	CcSEcCtD
Amiodarone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00657	CcSEcCtD
Amiodarone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00624	CcSEcCtD
Amiodarone—THRA—spinal cord—amyotrophic lateral sclerosis	0.0006	0.0318	CbGeAlD
Amiodarone—CACNA2D2—spinal cord—amyotrophic lateral sclerosis	0.000594	0.0315	CbGeAlD
Amiodarone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000567	0.0059	CcSEcCtD
Amiodarone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000561	0.00583	CcSEcCtD
Amiodarone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00563	CcSEcCtD
Amiodarone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000535	0.00556	CcSEcCtD
Amiodarone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00538	CcSEcCtD
Amiodarone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00533	CcSEcCtD
Amiodarone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00528	CcSEcCtD
Amiodarone—THRB—nervous system—amyotrophic lateral sclerosis	0.000506	0.0268	CbGeAlD
Amiodarone—THRA—nervous system—amyotrophic lateral sclerosis	0.000506	0.0268	CbGeAlD
Amiodarone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00525	CcSEcCtD
Amiodarone—CACNA2D2—nervous system—amyotrophic lateral sclerosis	0.0005	0.0265	CbGeAlD
Amiodarone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000499	0.00518	CcSEcCtD
Amiodarone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000497	0.00516	CcSEcCtD
Amiodarone—THRA—central nervous system—amyotrophic lateral sclerosis	0.000487	0.0258	CbGeAlD
Amiodarone—THRB—central nervous system—amyotrophic lateral sclerosis	0.000487	0.0258	CbGeAlD
Amiodarone—Cough—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00501	CcSEcCtD
Amiodarone—CACNA2D2—central nervous system—amyotrophic lateral sclerosis	0.000482	0.0255	CbGeAlD
Amiodarone—THRA—cerebellum—amyotrophic lateral sclerosis	0.000476	0.0252	CbGeAlD
Amiodarone—THRB—cerebellum—amyotrophic lateral sclerosis	0.000476	0.0252	CbGeAlD
Amiodarone—CACNA2D2—cerebellum—amyotrophic lateral sclerosis	0.000471	0.025	CbGeAlD
Amiodarone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00488	CcSEcCtD
Amiodarone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000465	0.00483	CcSEcCtD
Amiodarone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00478	CcSEcCtD
Amiodarone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000455	0.00473	CcSEcCtD
Amiodarone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00469	CcSEcCtD
Amiodarone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00469	CcSEcCtD
Amiodarone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00466	CcSEcCtD
Amiodarone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00461	CcSEcCtD
Amiodarone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00459	CcSEcCtD
Amiodarone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00044	0.00458	CcSEcCtD
Amiodarone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000438	0.00456	CcSEcCtD
Amiodarone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00453	CcSEcCtD
Amiodarone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00447	CcSEcCtD
Amiodarone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00438	CcSEcCtD
Amiodarone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00424	CcSEcCtD
Amiodarone—CACNA1H—nervous system—amyotrophic lateral sclerosis	0.000406	0.0215	CbGeAlD
Amiodarone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00421	CcSEcCtD
Amiodarone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00418	CcSEcCtD
Amiodarone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00413	CcSEcCtD
Amiodarone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00408	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00405	CcSEcCtD
Amiodarone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000389	0.00404	CcSEcCtD
Amiodarone—THRA—brain—amyotrophic lateral sclerosis	0.000387	0.0205	CbGeAlD
Amiodarone—THRB—brain—amyotrophic lateral sclerosis	0.000387	0.0205	CbGeAlD
Amiodarone—Pain—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00401	CcSEcCtD
Amiodarone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00401	CcSEcCtD
Amiodarone—CACNA2D2—brain—amyotrophic lateral sclerosis	0.000383	0.0203	CbGeAlD
Amiodarone—CACNA1H—cerebellum—amyotrophic lateral sclerosis	0.000382	0.0202	CbGeAlD
Amiodarone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000374	0.0198	CbGeAlD
Amiodarone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000372	0.00386	CcSEcCtD
Amiodarone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00383	CcSEcCtD
Amiodarone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000359	0.00373	CcSEcCtD
Amiodarone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00371	CcSEcCtD
Amiodarone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00371	CcSEcCtD
Amiodarone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00346	CcSEcCtD
Amiodarone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00336	CcSEcCtD
Amiodarone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00332	CcSEcCtD
Amiodarone—CACNA1H—brain—amyotrophic lateral sclerosis	0.00031	0.0164	CbGeAlD
Amiodarone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00321	CcSEcCtD
Amiodarone—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000308	0.0163	CbGeAlD
Amiodarone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000298	0.0031	CcSEcCtD
Amiodarone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00298	CcSEcCtD
Amiodarone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00296	CcSEcCtD
Amiodarone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00295	CcSEcCtD
Amiodarone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000283	0.00294	CcSEcCtD
Amiodarone—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000283	0.015	CbGeAlD
Amiodarone—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000275	0.0146	CbGeAlD
Amiodarone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000268	0.00279	CcSEcCtD
Amiodarone—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000245	0.013	CbGeAlD
Amiodarone—ADRB1—nervous system—amyotrophic lateral sclerosis	0.000241	0.0128	CbGeAlD
Amiodarone—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.000232	0.0123	CbGeAlD
Amiodarone—CYP2A6—brain—amyotrophic lateral sclerosis	0.00023	0.0122	CbGeAlD
Amiodarone—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000219	0.0116	CbGeAlD
Amiodarone—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000218	0.0115	CbGeAlD
Amiodarone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000214	0.0114	CbGeAlD
Amiodarone—ADRB1—brain—amyotrophic lateral sclerosis	0.000184	0.00977	CbGeAlD
Amiodarone—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000184	0.00977	CbGeAlD
Amiodarone—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000177	0.0094	CbGeAlD
Amiodarone—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000177	0.00938	CbGeAlD
Amiodarone—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000173	0.00919	CbGeAlD
Amiodarone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000168	0.00892	CbGeAlD
Amiodarone—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000156	0.00825	CbGeAlD
Amiodarone—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.00015	0.00794	CbGeAlD
Amiodarone—KCNH2—brain—amyotrophic lateral sclerosis	0.000141	0.00746	CbGeAlD
Amiodarone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000129	0.00683	CbGeAlD
Amiodarone—CYP1A1—brain—amyotrophic lateral sclerosis	0.000119	0.0063	CbGeAlD
Amiodarone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000114	0.00605	CbGeAlD
Amiodarone—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000112	0.00596	CbGeAlD
Amiodarone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00011	0.00583	CbGeAlD
Amiodarone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000108	0.00573	CbGeAlD
Amiodarone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000108	0.0057	CbGeAlD
Amiodarone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000106	0.0056	CbGeAlD
Amiodarone—ABCB1—spinal cord—amyotrophic lateral sclerosis	9.59e-05	0.00508	CbGeAlD
Amiodarone—CYP2D6—brain—amyotrophic lateral sclerosis	8.59e-05	0.00455	CbGeAlD
Amiodarone—ABCB1—nervous system—amyotrophic lateral sclerosis	8.08e-05	0.00428	CbGeAlD
Amiodarone—ABCB1—central nervous system—amyotrophic lateral sclerosis	7.78e-05	0.00412	CbGeAlD
Amiodarone—ABCB1—cerebellum—amyotrophic lateral sclerosis	7.61e-05	0.00403	CbGeAlD
Amiodarone—ABCB1—brain—amyotrophic lateral sclerosis	6.18e-05	0.00327	CbGeAlD
Amiodarone—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	3.78e-05	0.000986	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.71e-05	0.000967	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.7e-05	0.000965	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.68e-05	0.00096	CbGpPWpGaD
Amiodarone—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.68e-05	0.000958	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.66e-05	0.000954	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.65e-05	0.000951	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.000931	CbGpPWpGaD
Amiodarone—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.52e-05	0.000918	CbGpPWpGaD
Amiodarone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.5e-05	0.000913	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.49e-05	0.000909	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.47e-05	0.000904	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.47e-05	0.000904	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.46e-05	0.000902	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	3.46e-05	0.000902	CbGpPWpGaD
Amiodarone—EBP—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.39e-05	0.000885	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.38e-05	0.000882	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.37e-05	0.000879	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.34e-05	0.000871	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.33e-05	0.000867	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.28e-05	0.000854	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.22e-05	0.000839	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.2e-05	0.000834	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.18e-05	0.000829	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.17e-05	0.000827	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.15e-05	0.00082	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.12e-05	0.000813	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.09e-05	0.000806	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.05e-05	0.000795	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	3.03e-05	0.000789	CbGpPWpGaD
Amiodarone—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-05	0.00078	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.96e-05	0.000771	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.95e-05	0.000769	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.91e-05	0.00076	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.83e-05	0.000737	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.77e-05	0.000723	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.76e-05	0.000719	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	2.74e-05	0.000713	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.74e-05	0.000713	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.74e-05	0.000713	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.72e-05	0.00071	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.61e-05	0.000679	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.6e-05	0.000679	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.6e-05	0.000678	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.58e-05	0.000674	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.58e-05	0.000674	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.57e-05	0.00067	CbGpPWpGaD
Amiodarone—EBP—Metabolism—APOE—amyotrophic lateral sclerosis	2.57e-05	0.000669	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.54e-05	0.000662	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.52e-05	0.000657	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.52e-05	0.000656	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.51e-05	0.000654	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.5e-05	0.000653	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.5e-05	0.000652	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.48e-05	0.000647	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.42e-05	0.00063	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.41e-05	0.000629	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.41e-05	0.000628	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.38e-05	0.000622	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.37e-05	0.000618	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.37e-05	0.000618	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.37e-05	0.000618	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.37e-05	0.000617	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.36e-05	0.000616	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.34e-05	0.000609	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.33e-05	0.000608	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.33e-05	0.000606	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.28e-05	0.000593	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.22e-05	0.000579	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.21e-05	0.000576	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.2e-05	0.000573	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.19e-05	0.00057	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.17e-05	0.000565	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.15e-05	0.000561	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.15e-05	0.000561	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.12e-05	0.000553	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.11e-05	0.000551	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.11e-05	0.000551	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.07e-05	0.00054	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.000539	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.06e-05	0.000538	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.06e-05	0.000538	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.05e-05	0.000534	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.03e-05	0.000528	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.01e-05	0.000525	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.98e-05	0.000517	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.98e-05	0.000516	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.000514	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.95e-05	0.000507	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.95e-05	0.000507	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.93e-05	0.000504	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.93e-05	0.000503	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.93e-05	0.000503	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.91e-05	0.000499	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.9e-05	0.000495	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.89e-05	0.000494	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.89e-05	0.000492	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.87e-05	0.000487	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.83e-05	0.000477	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.83e-05	0.000477	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—APOE—amyotrophic lateral sclerosis	1.83e-05	0.000477	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000474	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.8e-05	0.000469	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.8e-05	0.000469	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.78e-05	0.000464	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.76e-05	0.00046	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.76e-05	0.000458	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.76e-05	0.000458	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.75e-05	0.000457	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.71e-05	0.000447	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.71e-05	0.000446	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.69e-05	0.000441	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.66e-05	0.000433	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.65e-05	0.000431	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.65e-05	0.00043	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.65e-05	0.00043	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.65e-05	0.00043	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.64e-05	0.000427	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.000427	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.63e-05	0.000425	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.62e-05	0.000423	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.57e-05	0.00041	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.57e-05	0.000409	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.55e-05	0.000405	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.55e-05	0.000403	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.54e-05	0.000402	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.54e-05	0.000401	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.53e-05	0.000399	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.51e-05	0.000393	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.5e-05	0.000391	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.49e-05	0.000389	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.44e-05	0.000375	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.000369	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.41e-05	0.000367	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.4e-05	0.000365	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.39e-05	0.000363	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.39e-05	0.000363	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.38e-05	0.000361	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.38e-05	0.000359	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.32e-05	0.000343	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	0.000341	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.3e-05	0.000338	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.28e-05	0.000335	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.27e-05	0.000332	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.27e-05	0.000332	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.25e-05	0.000327	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.2e-05	0.000312	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.19e-05	0.000311	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.19e-05	0.000311	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	0.00031	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.16e-05	0.000303	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.16e-05	0.000302	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.0003	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.14e-05	0.000296	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.13e-05	0.000295	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.12e-05	0.000292	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000284	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.08e-05	0.000282	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.00028	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.07e-05	0.000279	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.07e-05	0.000278	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.06e-05	0.000275	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.04e-05	0.000272	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.02e-05	0.000266	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.02e-05	0.000265	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.01e-05	0.000264	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	9.84e-06	0.000256	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	9.84e-06	0.000256	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.79e-06	0.000255	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	9.75e-06	0.000254	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.74e-06	0.000254	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.47e-06	0.000247	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.19e-06	0.00024	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	9.03e-06	0.000235	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.98e-06	0.000234	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.88e-06	0.000232	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.88e-06	0.000231	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.78e-06	0.000229	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.57e-06	0.000223	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.46e-06	0.000221	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.44e-06	0.00022	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.33e-06	0.000217	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.08e-06	0.000211	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.01e-06	0.000209	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.01e-06	0.000209	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.76e-06	0.000202	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.74e-06	0.000202	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.64e-06	0.000199	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.59e-06	0.000198	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.31e-06	0.00019	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.24e-06	0.000189	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.11e-06	0.000185	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.97e-06	0.000182	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.84e-06	0.000178	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.81e-06	0.000177	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.71e-06	0.000175	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.43e-06	0.000168	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	6.39e-06	0.000166	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.24e-06	0.000163	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.15e-06	0.00016	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.1e-06	0.000159	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.02e-06	0.000157	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	5.85e-06	0.000153	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.77e-06	0.00015	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.61e-06	0.000146	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.6e-06	0.000146	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.49e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.3e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.29e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.28e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.01e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.86e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.72e-06	0.000123	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.63e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.62e-06	0.00012	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.61e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.38e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.36e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.34e-06	0.000113	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.34e-06	0.000113	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.3e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.28e-06	0.000112	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.23e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.01e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.99e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.95e-06	0.000103	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.68e-06	9.59e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.57e-06	9.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.56e-06	9.29e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.48e-06	9.08e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.38e-06	8.81e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.37e-06	8.78e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.28e-06	8.56e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.25e-06	8.48e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.16e-06	8.24e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.02e-06	7.88e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-06	7.79e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.84e-06	7.4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.78e-06	7.25e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.74e-06	7.14e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.61e-06	6.8e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.44e-06	6.37e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.39e-06	6.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.28e-06	5.96e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.25e-06	5.86e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.23e-06	5.81e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.15e-06	5.59e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.91e-06	4.97e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-06	3.83e-05	CbGpPWpGaD
